The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract (LGT): First Clinical Experience seems to be a highly promising Imaging agent for the diagnosis and management of LGT tumors, potentially opening new applications for tumor staging or restaging.